Interferon 7 (IFN-3') is a pleiotropic cytokine secreted by T lymphocytes and natural killer (NK) cells and has been noted to be a first line of host defense in the control of viral infections. To examine further the role of this cytokine in the control of viral infections, mice with a targeted mutation in the IFN-7 gene were infected with influenza virus, and the in vivo antibody and ceil-mediated immune response to viral infection were examined. In addition, cell lines and clones were derived from the immunized animals and the in vitro cytokine production and cytotoxic T lymphocyte (CTL) response were analyzed. The absence of IFN-3' led to increased production of influenza-specific IgG1, IL-4, and IL-5 as compared to wild-type littermate control animals. In contrast, there was no difference noted in the development of an effective CTL response between IFN-7-deficient and wild-type animals. In this model of experimental influenza infection, IFN-7 is not necessary for the development of an effective humoral or cellular immune response to challenge with this respiratory virus.
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I
FN-% also known as immune or type II interferon, is a pleiotropic cytokine secreted by T lymphocytes and NK cells. It has long been believed to be a first line of host defense in the control of viral infections. Its effects are multifaceted and include both direct and indirect activities. The direct antiviral activity attributed to IFN-% as well as to IFN-cr and IFN-B, includes the induction of proteins and enzymes that inhibit viral multiplication by impairing accumulation of viral-specific mRNA, double-stranded RNA, and proteins (1) . In addition, dass I MHC-restricted CTL have been shown to secrete IFN-7 upon antigenic stimulation (2) (3) (4) and the differentiation of precursors to activated CTL has been reported to be dependent on the action of IFN-7 (5, 6) . The indirect effects of IFN-7 include inhibition of cell growth and upregulation of class I and II MHC molecules on APC, specifically macrophages (7, 8) . IFN-3' may also regulate antigen processing by augmenting the proteolysis and peptide transport machinery in APC (9, 10) .
The role of CTL in the host defense to influenza infection has been examined by a number of investigators (11) (12) (13) (14) (15) (16) . Both heterogeneous populations of immune spleen cells and cloned influenza-specific CTL have been shown to lyse vitally infected, MHC-matched target cells in vitro and to reduce lung virus titers and promote survival after adoptive transfer to influenza virus-infected mice in vivo. The role of secreted cytokines by activated CTL, most notably IFN-% in the observed in vitro and in vivo antiviral effects has been unclear, and the relative importance of direct cytolysis versus soluble factors released by CTL has not been definitively determined. Although it has been suggested that CTL mediate their antiviral protective effects in vivo via direct cytolysis of virusinfected ceils (16) , the potential role of soluble mediators released by the dones in high local concentrations could not be ruled out as playing a significant role in recovery from influenza infection. The role that IFN-3, plays in clearance of influenza virus mediated by CD4 + MHC class II-restricted cytotoxic T cells is even less clear. In general, CD4 + cytotoxic T cells that have been shown to exhibit cytolytic effector functions in vitro and in vivo have belonged to the Thl subset of routine helper T cell dones (17, 18 , and Graham, M. B., unpublished observations) which secrete IFN-7 and IL-2 upon stimulation (19) . These MHC class II-restricted CTL have been shown to promote virus dearance when adoptively transferred into influenza-infected animals.
Recently, it has become possible to directly examine the role of cytokines in immune and inflammatory responses using gene disruption strategies (20) (21) (22) . In this report, we examine the in vivo cellular and humoral immune response to infection with type A influenza virus in mice with a targeted mutation in the IFN-7 gene. In addition, the in vitro and in vivo antiviral effector activities of virus-specific cytolytic T lymphocytes derived from these animals are compared with those of wild-type (WT) 1 littermates for antiviral activity in adoptive transfer. We show that IFN-3' is not necessary for either recovery from experimental influenza infection or for the in vivo effector activity of influenza-specific CD4 + or CD8 + cytotoxic T cells which are cytolytic in vitro and protective in vivo.
Materials and Methods
Animals. Male (8-9 wk of age) and female (6-7 wk of age) mice homozygous for a targeted disruption of the/FN-'y gene (IFN-3,o/o H_2 b) and WT littermates (IFN-3, '~t/wt, H-2 b) were derived as previously described (23) . Murine pathogen-free male and female C57B1/6 (H-2 b) 4-6-wk-old mice were purchased from Taconic Farms, Inc. (Germantown, NY) and used at 6-9 wk of age. Viruses. Influenza virus strain A/JAP/57 (A/Japan/305/57
[H2N2]) was grown in the allantoic cavity of 10-d-old embryonated hen eggs and stored as infectious allantoic fluid as previously described (24) . Determination of virus titer, expressed as hemagglutinating units (HALl), was done as previously described (24 influenza-specific bulk cultures clones are described in detail risewhere (25) with a few minor modifications. Briefly, spleen cells from immunized IFN-3, ~176 and IFN-3, w'/wt (described above) were harvested 1, 3, or 4 wk after immunization. In vitro secondary bulk cultures from individual mice were established by infecting one third of the autologous spleen cells with influenza A/JAP/57, combining these cells with the two-thirds uninfected splenocytes, and culturing the cells at a density of 5 x 10" cells per ml for 14 d in IMDM (GIBCO BILL), 10% FIIFCS, 1% glutamine, 5 x 10 -s M 2-ME, and antibiotics (complete media). Subsequently, the bulk cultures were stimulated in vitro with influenza A/JAP/57 virusinfected, "),-irradiated (2,000 tad) C57B1/6 spleen cells every 14 d with 10 U/ml human recombinant IL-2 (hulLlL-2; Biosource In-1 Abbreviations used in this paper: HALT, hemagglutinating unit; HIFCS, heat-inactivated FCS; huR.IL-2, human recombinant IL-2; NP, nucleoprotein; WT, wild type. ternational, Inc., Camarillo, CA) in complete media. Clones were derived by limiting dilution of viable cells from in vitro secondary bulk cultures. Clones were selected, expanded, and maintained in the presence of influenza A/JAP/57 virus-infected, 3,-irradiated C57B1/6 spleen cells in complete media with 10 U/ml huRIl~2. The clones were restimulated every 7 d in six-well cluster tissue culture plates (model 3506; Costar Corp., Cambridge, MA) containing 10S/ml clone cells, 5 x 10S/ml infected, irradiated C57B1/6 spleen cells, and 10 U/ml huRIL-2 in complete media.
Cytokine Production. Supernatants were collected from in vitro secondary bulk cultures 48 h after stimulation and frozen at -20~ Supernatants from clones were harvested 48 h after stimulation in the absence of huRIL-2 and frozen at -20~ Production of IFN-3, was assayed by ELISA as previously described (26) The plates were then washed three times with lx ELISA wash buffer (0.02 M NaHzPO4, 0.1 M Na2HPO4, 1.5 M NaC1, and 0.5% Tween 20, pH 7.4). Plates were blocked for 1 h with ELISA working and blocking buffer (2% BSA and 0.1% Tween 20 in lx PBS, pH 7.3). Plates were washed three times, and serial dilutions of sera from each animal (diluted in working buffer) were added to the plate and incubated for 2 h at 37~ Plates were washed three times, a 1:1,000 dilution of alkaline phosphatase-conjugated goat anti-mouse IgG1 or IgG2a (Southern Biotechnology Associates, Birmingham, AL) was added to each well, and plates were incubated for 2 h at 37~ The plates were washed a final three times, 1 mg/ml p-nitrophenyl phosphate disodium (Sigma Chemical Co.) in substrate buffer (1 M diethanolamine, 0.1 mg/ml MgC12, and 0.2% NAN3) was added to each well, and a color change was allowed to develop for 1 h. OD read at 415 nm on an ELISA microplate reader (Bio Tek Instruments, Inc.). Assays for Cell-mediated Cytotoxicity. The SlCr-release cytotoxicity assay was carried out as previously described (24) . Briefly, 10' target cells, either EL-4 or LB15.13, were either left uninfected, infected with influenza A/JAP/57, or pulsed with 1.0 t~g/ml NP 366-379 in the presence of SlCr for 1.5 h at 37~ Targets were then washed three times and plated at 5 x 103 cells per well in 96-well, flat-bottom, microtiter tissue culture plates in 0.1-ml vol of RPMI plus 10% HIFCS. Effector cells were added in a 0.1-ml vol of RPMI plus 10% HIFCS to appropriate wells in quadruplicate. E/T ratios ranged from 5:1 to 100:1, depending on the assay. The plates were incubated at 37~ in 10% CO2 for 3 h. From each well, 0.1 ml of supernatant was removed and counted on a gamma counter (Isomedic; ICN Biomedicals, Inc., Costa Mesa, CA). The percent specific lysis was determined as previously described (16) . SEM were always <5% of the mean value and are omitted.
Intranasal Influenza Virus Inoculation. Intranasal inoculation of mice was performed as previously described (16) . The procedure was modified from that described by using light anesthesia from methoxyflurane (Pitman-Moore, Mundelein, IL). To evaluate a dose-response to intranasal virus, animals received serial 10-fold dilutions of allantoic fluid in cold PBS ranging from 10 .2 to 10 -6, and animals were watched daily for morbidity and/or mortality. LDs0 values were calculated according to a modified Spearman and Karber method (27) .
Adaptive Transfer Procedure. Adoptive transfer of day 6 viable cloned cells was performed as previously described (16). 9-wk-old male C57B1/6 mice were intranasally inoculated with 10 LDs0 influenza A/JAP/57 virus and within 30 min, 107 clone cells in 0.5 ml IMDM (GIBCO BRL) were injected intravenously. Control mice were injected intravenously with 0.5 ml IMDM alone. Mice were watched daily for 21 d for morbidity and/or mortality.
Results

Ability of lFN-7-deficient Mice and WT Littermates to Generate a Cytotoxic T Cell Response to Challenge with Influenza. To
evaluate the rule of IFN-'y in the routine host response to infectious influenza virus, we immunized H-2 b haplotype mice generated with a targeted mutation in the IFN-q( gene, and with no demonstrable IFN-'y production, and their WT littermates. Six female mice homozygous for the mutation in the IFN-'), gene, designated IFN-q( deficient, and six WT female littermates were initially analyzed for the ability to mount a CTL response to immunization with influenza A/JAP/57 virus. In vitro secondary bulk cultures of immune splenocytes from both IFN-'u deficient and WT animals were able to lyse vitally infected targets with similar efficiencies (Fig. 1) . In addition, MHC dass II-negative, H-2Db-expressing EL4 ceUs treated with a synthetic peptide corresponding to type common influenza NP were also recognized equally well by IFN-~, deficient and WT bulk cultures. This peptide (amino acid 366-379) mimics an immunodominant epitope on the NP recognized by class I MHC-restricted T lymphocytes from H-2 b haplotype mice in association with H-2D b (28) . Analysis of in vivo primary CTL responses by standard chromium release assay did not reveal demonstrable influenza- specific CTL from either IFN-3' deficient or WT littermates (data not shown).
Cytokine Production by In Vitro Secondary Bulk Cultures from IFN-T Deficient and WT Mice.
To ensure that splenocytes from immunized IFN-q/-deficient mice did not produce any measurable IFN-3,, supernatants from in vitro secondary bulk cultures were analyzed for the production of IFN-'),. As expected, IFN-y-deficient bulk cultures released no detectable IFN-% whereas bulk cultures from WT animals produced variable amounts of IFN-'y ( Table 1 ). The same supernatants were then analyzed for the production of IL-2, IL-4, and IL-5 (Table 1 ). In the absence of IFN-% the production of IL-4 and IL-5 was significantly higher than that in WT bulk cultures. There was no statistical difference in the amounts of IL-2 produced by the IFN-'),-deficient bulk cultures versus those from WT animals. Subsequent stimulation of bulk cultures with irradiated, virus-infected splenocytes from WT mice yielded identical results (data not shown). Stimulation of IFN-~/-defieient cultures with irradiated, infected splenocytes from normal mice that have an intact IFN-3' gene, did not alter the cytokine production profile of the cultures.
Humoral Immune Response to Immunization with Influenza Virus in IFN-7-deficient and WT Mice. IFN-3, has been
reported to be crucial in antibody class switch during the maturation of a humoral immune response (29, 30) . To assess the impact of IFN-3, in determining the humoral immune response of the animals to immunization with influenza, mice were inoculated parenterally with influenza virus, and sera from serial bleeds of the immunized animals was assayed for influenza-specific IgG1 and IgG2a antibodies ( Table 2 ). In mice lacking IFN-'),, the IgG1 antibody response to type A influenza was significantly higher than the response of the WT animals. This finding is in agreement with previous studies (29) that have shown that IFN-3' blocks the ability of B cells to respond to IL-4, thereby decreasing synthesis of IgG1 and IgE. Thus, in the absence of IFN-3, and an increased production of IL-4 ( to IgG1 is favored. Although the production of IgG2a was slightly diminished in the IFN-'y-deficient animals, the level was not significantly lower than the amount made by the WT animals. This result is in keeping with previous in vitro studies which examined the effect of neutralizing anti-IFN-y antibody on isotype switch during humoral immune responses (31) . Analysis of preimmune serum samples from these animals revealed no detectable levels of influenza-specific IgG1 or IgG2a (data not shown). (Fig. 2) . EL-4 cells express only dass I MHC molecules of the H-2 b haplotype. The IFN-'y deficient done G-4D7 expresses CD4 as assessed by flow cytometry (data not shown). This T lymphocyte clone was unable to lyse viraUy infected or peptide-treated EL-4 targets, but did lyse vitally infected LB15.13 target cells which express both MHC class I and II for H-2 b haplotype (Fig. 2) . All of these clones have been stable in culture for more than 6 mo. None of the clones from IFN-'y-deficient mice secreted measurable levels of IFN % whereas clones W-16G8 and B1.11 produced 64 U/ml and 72 U/ml IFN-7 upon stimulation, respectively. Clones G-11E4, G-11D6, W-16G8, and B1.11 had no detectable levels of IL-2, IL-4, or IL-5, whereas the CD4 + IFN-3,-deficient clone G-4D7 secreted measurable levels of IL-2, IL-4, and IL-5 (159, 59, and 960 pg/ml, respectively).
Evaluation of In Vitro and In Vivo Effector Function of Clones from IFN-7-deficient and WT
Our laboratory has previously examined the ability of cloned CTL to promote recovery after transfer into lethally infected animals by adoptive transfer experiments (16) . To assess the function of CTL dones lacking a functional IFN-'y gene, cloned T cells from the mutant and WT mice were adoptively transferred into histocompatible C57B1/6 mice challenged with a lethal intranasal inoculation of influenza (Fig.  3) . The three IFN-'y-deficient clones G-4D7, G-11D6, and G-11E4, and the WT clone B1.11 each promoted recovery from lethal viral challenge with influenza A/JAP/57. Although IFN-3' has been noted to have potent antiviral activity, and has been suggested to play a critical role in the function of virus-specific CTL (2, 4), production of IFN-3, by either CD4 + or CD8 + cytotoxic T cells is not required for expression of antiviral effector activity in vivo. WT clone W-16G8 did not demonstrate any in vivo protective capability despite its ability to lyse virally infected target cells and produce IFN-3' in vitro. The defect in clone W-16G8 is currently being evaluated.
In Vivo Response to Influenza Infection in IFN-y-deficient and WT Mice.
Since either CD4 + or CD8 + IFN-3,-deficient T lymphocyte clones promoted recovery from lethal influenza infection upon adoptive transfer, we next examined the response of IFN-3,-deficient mice to pulmonary infection with influenza virus. To assess the impact of IFN-'y expression on susceptibility to infection with influenza virus, WT and IFN-3/-deficient mice were inoculated intranasally with varying doses of infectious mouse-adapted influenza virus. Although at the highest doses of virus given, the WT animals died in a slightly faster time frame (ranging from 24 to 48 h) during the first 7 d after infection, both the time to death and minimal lethal dose of virus were identical for both the IFN-'y-deficient and WT animals (Fig. 4) .
Discussion
IFN-3, is a pleiotropic cytokine with wide-ranging immunomodulatory effector functions. In this model of ex- perimental influenza infection, its absence did lead to differential antibody response and cytokine production as compared with controls, but did not affect the development of an effective ceU-mediated immune response to a respiratory virus. The role that IFN-'), plays in differentiation of precursors into CTL, thereby influencing the cell-mediated immune response, has been controversial. Originally it was thought that IFN-3, was an essential cofactor in these precursors and was necessary for CD8 + T cells to acquire cytolytic activity (5, 6) . Other studies have indicated that IFN-'y is not necessary for the induction of CTL in MLC and that IL-2 is the prime cytokine needed for growth and differentiation of CTL (32, 33) . Additional lines of investigation have also implicated IL-4 as a prime inducer of CTL (34, 35) . In the bulk cultures generated from IFN-3~-deficient mice, variable amounts of both IL-2 and IL-4 were produced, thus potentially playing a significant role in the generation of cytotoxic T cells in these populations in the absence of IFN-% The results of the adoptive transfer experiment are consistent with speculations made previously by our laboratory that in experimental influenza infection, direct cytolysis of vitally infected cells may be the primary mechanism by which clonal populations of CD8 + CTL express their antiviral effector activity in vivo (16) . Similarly, IFN-'y deficiency did not have a significant impact on recovery from infection in this experimental model for influenza infection. As shown previously, IFN-3,-deficient mice are unable to control infection with the intracellular mycobacterium, Mycobacterium boris (BCG strain) (23) . Also, IFN-'y receptor-deficient mice have been shown to be unable to control infection with the intracellular bacterium, Listeria monocTtogenes (36) . Furthermore, in experimental vaccinia virus infection, vaccinia virus is le-thai in IFN-~/receptor-deficient mice, suggesting that in this viral infection, IFN-3, may play a critical modulating role (36) . It seems likely, therefore, that the importance of IFN-~/ in clearance of a pathogen and recovery will vary among microorganisms.
Previous studies (17) from this laboratory have demonstrated that influenza-specific CD4 + T lymphocytes can eliminate infectious virus and promote recovery from lethal experimental infection when CD4 + T cell clones are adoptively transferred in vivo. An interesting feature of these early studies was the finding that protective CD4 + T cell populations express specific cytolytic activity similar to influenza-specific CD8 + T lymphocytes. In addition, these protective CD4 + T lymphocyte populations secrete a constellation of cytokines upon antigenic stimulation, including IL-2 and IFN-% and fall into the subset ofThl T cells. In the present report, clone G-4D7, derived from an IFN-y-deficient animal, was able to lyse virally infected MHC class II expressing targets in vitro and promote recovery from lethal viral challenge in vivo. The mechanisms by which CD4 + T cells may be involved in promoting recovery from viral infection include both humoral and cellular immune responses. It is well established that in experimental influenza infection, CD4 + T cells can support antigen-specific B cell responses with production of influenza-specific antibodies (37) . The mechanism(s) by which clone G-4D7 acts could include specific antibody production as a result orb cell help and cytokine production, in addition to direct cytolytic effector activity on viraUy infected respiratory epithelial cells. In this model, IFN-3, does not appear to be necessary for either the in vitro or in vivo effector function of CD4 + , influenza-specific, cytolytic clones.
In this study, there was no significant difference in the amounts of influenza-specific IgG2a antibody made by the IFN-qr-deficient or WT animals. IFN-y has potent effects on B cells, stimulating B cell proliferation and active Ig secretion and isotype switch from IgM to IgG2a (29) . IgG2a synthesis may be promoted by other cytokines, such as IL-2, since it has been shown that although IFN-3' produced by Thl cells promotes IgG2a synthesis, neutralization of IFN-y by the addition of anti-IFN-3, antibody does not affect the IgG2a antibody production promoted by cytokines from CD4 + Thl T cells (31) . In immune responses to viral infections with both RNA and DNA viruses, IgG2a is the dominant antibody response, followed by IgG1 (38) . The IgG2a response to viral infection has been speculated to be advantageous because of its ability to fix complement and bind Fc receptors on both macrophages and NK cells, potentially enhancing the ability to combat intracellular infections (30) . In these experiments, the viral-specific IgG1 antibody response was significantly higher in the IFN-~/-deficient versus the WT animal, presumably reflecting increased production of IL-4 in the absence of IFN-~/and therefore a greater switch to IgG1 production (20) .
These observations differ from those made in mice lacking the IFN-3, receptor (36) , where there was no demonstrable difference in IgG1 antibody response to immunization with OVA, but a reduced IgG2a antibody response in the mutant animals. An intriguing explanation for this difference is that IFN-3' receptor-defident mice still produce IFN-% and potentially a second receptor for IFN-3' exists, such as was discovered for IL-1 (39) . Alternatively, studies have shown that different cytokines can cross-compete for the same receptor (40) and may account for the lack of a difference in IgG2a production in our experimental model.
In conclusion, we have shown that animals lacking endogenous production of IFN-3~ do not differ significantly from mice that make IFN-'y normally when challenged with influenza virus. Although deficient in IFN-% these animals express functional IFN-ol and IFN-~. Activities of these potent antiviral effectors could potentially account for the lack of differences observed. In addition, cloned CD4 + and CD8 § influenza-specific T cells do not require IFN-y to lyse vitally infected target cells in vitro or to clear influenza infection in vivo. The availability of cloned CTL from IFN-'y-deficient mice with in vitro and in vivo functional activities will enable us to study further the role different cytokines play in determining these effector mechanisms.
